Top

Journal of Cancer Research and Clinical Oncology

Published in:

03-04-2023 | Review

An update in the applications of exosomes in cancer theranostics: from research to clinical trials

Authors: Kourosh Shahraki, Paria Ghasemi Boroumand, Hajie Lotfi, Fatemeh Radnia, Hossein Shahriari, Saman Sargazi, Sedigheh Sadat Mortazavi, Milad Shirvaliloo, Sakine Shirvalilou, Roghayeh Sheervalilou

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2023

Abstract

Exosomes are nanosized extracellular vesicles secreted by nearly all viable cells following the fusing of multivesicular bodies and the plasma membrane and discharged into the encircling bodily fluids. Exosomes can transport cell-specific components from the source cell to the target cell. Given the enormous potential of exosomes as non-invasive diagnostic biomarkers and therapeutic nanovehicles. Lately, accumulated evidence has demonstrated that exosomes serve an important role in prognosis, diagnosis, and even treatment strategies. While several reviews have collective information on the biomedical application of exosomes, a comprehensive review incorporating updated and improved methodologies for beneficial applications of such vesicles in cancer theranostics is indispensable. In the current review, we first provided a comprehensive review of the introduction of exosomes, featuring their discovery, separation, characterization, function, biogenesis, secretion. The implications of exosomes as promising nanovehicles for drug and gene delivery, application of exosome inhibitors in the management of cancers, completed and ongoing clinical trials on the biological relevance of exosomes are then discussed in detail. As the field of exosome research grows, a better understanding of the subcellular parts and mechanisms involved in exosome secretion and targeting of specific cells will help figure out what their exact physiological functions are in the body.

Adams LS, Phung S, Chen S (2011) Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Wiley Online Library

Agrawal AK, Aqil F, Jeyabalan J, Spencer WA, Beck J, Gachuki BW, Alhakeem SS, Oben K, Munagala R, Bondada S (2017) Milk-derived exosomes for oral delivery of paclitaxel. Nanomed: Nanotechnol Biol Med 13(5):1627–1636

Airola MV, Shanbhogue P, Shamseddine AA, Guja KE, Senkal CE, Maini R, Bartke N, Wu BX, Obeid LM, Garcia-Diaz M (2017) Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation. Proc Natl Acad Sci 114(28):E5549–E5558PubMedPubMedCentral

Aqil F, Kausar H, Agrawal AK, Jeyabalan J, Kyakulaga A-H, Munagala R, Gupta R (2016) Exosomal formulation enhances therapeutic response of celastrol against lung cancer. Exp Mol Pathol 101(1):12–21PubMed

Aqil F, Jeyabalan J, Agrawal AK, Kyakulaga A-H, Munagala R, Parker L, Gupta RC (2017) Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct 8(11):4100–4107PubMed

Aqil F, Munagala R, Jeyabalan J, Agrawal AK, Kyakulaga A-H, Wilcher SA, Gupta RC (2019) Milk exosomes-natural nanoparticles for siRNA delivery. Cancer Lett 449:186–195PubMed

Arenz C, Gartner M, Wascholowski V, Giannis A (2001) Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase. Bioorg Med Chem 9(11):2901–2904PubMed

Arshad R, Fatima I, Sargazi S, Rahdar A, Karamzadeh-Jahromi M, Pandey S, Díez-Pascual AM, Bilal M (2021) Novel perspectives towards RNA-based nano-theranostic approaches for cancer management. Nanomaterials 11(12):3330PubMedPubMedCentral

Bai J, Duan J, Liu R, Du Y, Luo Q, Cui Y, Su Z, Xu J, Xie Y, Lu W (2020) Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. Asian J Pharm Sci 15(4):461–471PubMed

Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E (2012) Syndecan–syntenin–ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14(7):677–685PubMed

Barceló M, Castells M, Bassas L, Vigués F, Larriba S (2019) Semen miRNAs contained in exosomes as non-invasive biomarkers for prostate cancer diagnosis. Sci Rep 9(1):1–16

Bebelman MP, Smit MJ, Pegtel DM, Baglio SR (2018) Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther 188:1–11PubMed

Bobrie A, Colombo M, Raposo G, Théry C (2011) Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12(12):1659–1668PubMed

Byrne M, Tzekov R, Wang Y, Rodgers A, Cardia J, Ford G, Holton K, Pandarinathan L, Lapierre J, Stanney W (2013) Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eye. J Ocul Pharmacol Ther 29(10):855–864PubMed

Campanella C, Rappa F, Sciumè C, Marino Gammazza A, Barone R, Bucchieri F, David S, Curcurù G, Caruso Bavisotto C, Pitruzzella A (2015) Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery. Cancer 121(18):3230–3239PubMed

Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78(9):838–848PubMed

Canitano A, Iessi E, Spugnini EP, Federici C, Fais S (2016) Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma. Cancer Lett 376(2):278–283PubMed

Chen Y, Gao D-Y, Huang L (2015) In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 81:128–141PubMed

Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, Du L (2022) Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol 9:811971PubMedPubMedCentral

Chitra R, Harikumar KB (2018) The origin and functions of exosomes in cancer. Front Oncol. https://doi.org/10.3389/fonc.2018.00066CrossRef

Cho S, Yang HC, Rhee WJ (2019) Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis. Biosens Bioelectron 146:111749PubMed

Clark DJ, Fondrie WE, Liao Z, Hanson PI, Fulton A, Mao L, Yang AJ (2015) Redefining the breast cancer exosome proteome by tandem mass tag quantitative proteomics and multivariate cluster analysis. Anal Chem 87(20):10462–10469PubMedPubMedCentral

Colao IL, Corteling R, Bracewell D, Wall I (2018) Manufacturing exosomes: a promising therapeutic platform. Trends Mol Med 24(3):242–256PubMed

Colombo M, Moita C, Van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, Théry C, Raposo G (2013) Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126(24):5553–5565PubMed

Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289PubMed

Console L, Scalise M, Indiveri C (2019) Exosomes in inflammation and role as biomarkers. Clin Chim Acta 488:165–171PubMed

Dash M, Palaniyandi K, Ramalingam S, Sahabudeen S, Raja N (2021) Exosomes isolated from two different cell lines using three different isolation techniques show variation in physical and molecular characteristics. Biochim Biophys Acta (BBA)-Biomembr 1863(2):183490

Datta A, Kim H, Lal M, McGee L, Johnson A, Moustafa AA, Jones JC, Mondal D, Ferrer M, Abdel-Mageed AB (2017) Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett 408:73–81PubMedPubMedCentral

Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, Southall N, Hu X, Lal M, Mondal D (2018) High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep 8(1):1–13

De Rosa G, Salzano G, Caraglia M, Abbruzzese A (2012) Nanotechnologies: a strategy to overcome blood-brain barrier. Curr Drug Metab 13(1):61–69PubMed

De Toro J, Herschlik L, Waldner C, Mongini C (2015) Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol 6:203PubMedPubMedCentral

Denny WA, Wilson WR (2000) Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia. Expert Opin Investig Drugs 9(12):2889–2901PubMed

Didiot M-C, Hall LM, Coles AH, Haraszti RA, Godinho BM, Chase K, Sapp E, Ly S, Alterman JF, Hassler MR (2016) Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther 24(10):1836–1847PubMedPubMedCentral

Dijkstra S, Birker IL, Smit FP, Leyten GH, de Reijke TM, van Oort IM, Mulders PF, Jannink SA, Schalken JA (2014) Prostate cancer biomarker profiles in urinary sediments and exosomes. J Urol 191(4):1132–1138PubMed

Essandoh K, Yang L, Wang X, Huang W, Qin D, Hao J, Wang Y, Zingarelli B, Peng T, Fan G-C (2015) Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta (BBA)-Mol Basis Dis 1852(11):2362–2371

Fais S (2015) Evidence-based support for the use of proton pump inhibitors in cancer therapy. J Transl Med 13(1):1–5

Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D’Ilio S, Lugini L, Violante N, Azzarito T (2014) Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE 9(2):e88193PubMedPubMedCentral

Février B, Raposo G (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16(4):415–421PubMed

Figuera-Losada M, Stathis M, Dorskind JM, Thomas AG, Bandaru VVR, Yoo S-W, Westwood NJ, Rogers GW, McArthur JC, Haughey NJ (2015) Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties. PLoS ONE 10(5):e0124481PubMedPubMedCentral

Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44PubMed

Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S (2015) Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15(2–3):260–271PubMed

Gao Z, Yuan H, Mao Y, Ding L, Effah CY, He S, He L, Liu L-E, Yu S, Wang Y (2021) In situ detection of plasma exosomal microRNA for lung cancer diagnosis using duplex-specific nuclease and MoS 2 nanosheets. Analyst 146(6):1924–1931PubMed

Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y (2019) Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnol 17(1):1–18

Groot M, Lee H (2020) Sorting mechanisms for MicroRNAs into extracellular vesicles and their associated diseases. Cells 9(4):1044PubMedPubMedCentral

György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68(16):2667–2688PubMedPubMedCentral

Haney MJ, Suresh P, Zhao Y, Kanmogne GD, Kadiu I, Sokolsky-Papkov M, Klyachko NL, Mosley RL, Kabanov AV, Gendelman HE (2012) Blood-borne macrophage–neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery. Nanomedicine 7(6):815–833PubMed

Haney MJ, Zhao Y, Harrison EB, Mahajan V, Ahmed S, He Z, Suresh P, Hingtgen SD, Klyachko NL, Mosley RL (2013) Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases. PLoS ONE 8(4):e61852PubMedPubMedCentral

Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky M, Kabanov AV (2015) Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30PubMedPubMedCentral

Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding W (2016) Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res 18(1):1–14

Harding C, Heuser J, Stahl P (1983) Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97(2):329–339PubMed

Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75(2):193–208PubMed

Hong W, Chen Y, You K, Tan S, Wu F, Tao J, Chen X, Zhang J, Xiong Y, Yuan F (2020) Celebrex adjuvant therapy on coronavirus disease 2019: an experimental study. Front Pharmacol. https://doi.org/10.3389/fphar.2020.561674CrossRefPubMedPubMedCentral

Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329–335PubMedPubMedCentral

Huang L, Rong Y, Tang X, Yi K, Wu J, Wang F (2021) Circular RNAs are promising biomarkers in liquid biopsy for the diagnosis of non-small cell lung cancer. Front Mol Biosci 8:625722PubMedPubMedCentral

Hulsmans M, Holvoet P (2013) MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 100(1):7–18PubMed

Im E-J, Lee C-H, Moon P-G, Rangaswamy GG, Lee B, Lee JM, Lee J-C, Jee J-G, Bae J-S, Kwon T-K (2019) Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat Commun 10(1):1–17

Jeong K, Yu YJ, You JY, Rhee WJ, Kim JA (2020) Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model. Lab Chip 20(3):548–557PubMed

Jiang L, Vader P, Schiffelers R (2017) Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy. Gene Ther 24(3):157–166PubMed

Jin HZ, Hwang BY, Kim HS, Lee JH, Kim YH, Lee JJ (2002) Antiinflammatory constituents of celastrus o rbiculatus inhibit the NF-κB activation and NO production. J Nat Prod 65(1):89–91PubMed

Johnson JL, Ramadass M, He J, Brown SJ, Zhang J, Abgaryan L, Biris N, Gavathiotis E, Rosen H, Catz SD (2016) Identification of neutrophil exocytosis inhibitors (Nexinhibs), small molecule inhibitors of neutrophil exocytosis and inflammation: druggability of the small GTPase Rab27a. J Biol Chem 291(50):25965–25982PubMedPubMedCentral

Johnstone RM, Adam M, Hammond J, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262(19):9412–9420PubMed

Kalluri R (2016) The biology and function of exosomes in cancer. J Clin Investig 126(4):1208–1215PubMedPubMedCentral

Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977PubMedPubMedCentral

Kausar H, Jeyabalan J, Aqil F, Chabba D, Sidana J, Singh IP, Gupta RC (2012) Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Lett 325(1):54–62PubMed

Keller S, Sanderson MP, Stoeck A, Altevogt P (2006) Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107(2):102–108PubMed

Khan FM, Saleh E, Alawadhi H, Harati R, Zimmermann W-H, El-Awady R (2018) Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin. Cancer Biol Ther 19(1):25–33PubMed

Kim H, Rhee WJ (2020) Exosome-mediated let7c-5p delivery for breast cancer therapeutic development. Biotechnol Bioprocess Eng 25(4):513–520

Kim D-K, Kang B, Kim OY, Choi D-S, Lee J, Kim SR, Go G, Yoon YJ, Kim JH, Jang SC (2013) EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles 2(1):20384

Kim R, Lee S, Lee J, Kim M, Kim WJ, Lee HW, Lee MY, Kim J, Chang W (2018) Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy. BMB Rep 51(8):406PubMedPubMedCentral

Kirave P, Gondaliya P, Kulkarni B, Rawal R, Garg R, Jain A, Kalia K (2020) Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition. Oncotarget 11(13):1157PubMedPubMedCentral

Kobayashi M, Sawada K, Miyamoto M, Shimizu A, Yamamoto M, Kinose Y, Nakamura K, Kawano M, Kodama M, Hashimoto K (2020) Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer. Biochem Biophys Res Commun 527(1):153–161PubMed

Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, Inal JM, Bell JD, Lange S (2018) Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. Front Pharmacol 9:889PubMedPubMedCentral

Kouzegaran S, Shahraki K, Makateb A, Shahri F, Hatami N, Behnod V, Tanha AS (2017) Prognostic investigations of expression level of two genes FasL and Ki-67 as independent prognostic markers of human retinoblastoma. Oncol Res 25(4):471PubMedPubMedCentral

Kowalczuk L, Matet A, Dor M, Bararpour N, Daruich A, Dirani A, Behar-Cohen F, Thomas A, Turck N (2018) Proteome and metabolome of subretinal fluid in central serous chorioretinopathy and rhegmatogenous retinal detachment: a pilot case study. Transl vis Sci Technol 7(1):3–3PubMedPubMedCentral

Kulshreshtha A, Singh S, Ahmad M, Khanna K, Ahmad T, Agrawal A, Ghosh B (2019) Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions. Sci Rep 9(1):1–10

Lallemand T, Rouahi M, Swiader A, Grazide M-H, Geoffre N, Alayrac P, Recazens E, Coste A, Salvayre R, Nègre-Salvayre A (2018) nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe−/− mice. Arterioscler Thromb Vasc Biol 38(7):1479–1492PubMedPubMedCentral

Laraib U, Sargazi S, Rahdar A, Khatami M, Pandey S (2021) Nanotechnology-based approaches for effective detection of tumor markers: a comprehensive state-of-the-art review. Int J Biol Macromol. https://doi.org/10.1016/j.ijbiomac.2021.12.052CrossRefPubMed

Lee J, Lee H, Goh U, Kim J, Jeong M, Lee J, Park J-H (2016) Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles. ACS Appl Mater Interfaces 8(11):6790–6795PubMed

Leidal AM, Debnath J (2020) Unraveling the mechanisms that specify molecules for secretion in extracellular vesicles. Methods 177:15–26PubMedPubMedCentral

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981–984PubMedPubMedCentral

Li Z, Wang H, Yin H, Bennett C, Zhang H-G, Guo P (2018) Arrowtail RNA for ligand display on ginger exosome-like nanovesicles to systemic deliver siRNA for cancer suppression. Sci Rep 8(1):1–11

Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q, Zhang D, Song J, Cui D (2020) Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small 16(9):1903916

Lin D, Zhang H, Liu R, Deng T, Ning T, Bai M, Yang Y, Zhu K, Wang J, Duan J (2021) iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol 15(12):3430–3446PubMedPubMedCentral

Lobb RJ, Lima LG, Möller A (2017) Exosomes: key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol 67:3–10PubMed

Logozzi M, Mizzoni D, Angelini DF, Di Raimo R, Falchi M, Battistini L, Fais S (2018) Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes. Cancers 10(10):370PubMedPubMedCentral

Lott K, Li J, Fisk JC, Wang H, Aletta JM, Qu J, Read LK (2013) Global proteomic analysis in trypanosomes reveals unique proteins and conserved cellular processes impacted by arginine methylation. J Proteomics 91:210–225PubMedPubMedCentral

Lou W, Liu J, Gao Y, Zhong G, Chen D, Shen J, Bao C, Xu L, Pan J, Cheng J (2017) MicroRNAs in cancer metastasis and angiogenesis. Oncotarget 8:115787–115802PubMedPubMedCentral

Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, Chan WC, Cao W, Wang LV, Zheng G (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 10(4):324–332PubMed

Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277(43):41128–41139PubMed

Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F (2004) Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 96(22):1702–1713PubMed

Machida T, Tomofuji T, Maruyama T, Yoneda T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K (2016) miR-1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncol Rep 36(4):2375–2381PubMed

Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW (2015) Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int J Cancer 136(11):2616–2627PubMed

Manicum A-LE, Sargazi S, Razzaq S, Kumar GV, Rahdar A, Er S, Ain QU, Bilal M, Aboudzadeh MA (2022) Nano-immunotherapeutic strategies for targeted RNA delivery: Emphasizing the role of monocyte/macrophages as nanovehicles to treat glioblastoma multiforme. J Drug Deliv Sci Technol 71:103288

Martin L-A, Head JE, Pancholi S, Salter J, Quinn E, Detre S, Kaye S, Howes A, Dowsett M, Johnston SR (2007) The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo. Mol Cancer Ther 6(9):2458–2467PubMed

Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FW, Das S (2017) Obstacles and opportunities in the functional analysis of extracellular vesicle RNA–an ISEV position paper. Journal of Extracellular Vesicles 6(1):1286095PubMedPubMedCentral

Mathivanan S, Fahner CJ, Reid GE, Simpson RJ (2012) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40(D1):D1241–D1244PubMed

Möbius W, Ohno-Iwashita Y, Donselaar EGV, Oorschot VM, Shimada Y, Fujimoto T, Heijnen HF, Geuze HJ, Slot JW (2002) Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem 50(1):43–55PubMed

Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123(10):1603–1611PubMedPubMedCentral

Nara F, Tanaka M, Masuda-Inoue S, Yamasato Y, Doi-Yoshioka H, Suzuki-Konagai K, Kumakura S, Ogita T (1999) Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J Antibiot 52(6):531–535

Nazarenko I, Rupp A-K, Altevogt P (2013) Exosomes as a potential tool for a specific delivery of functional molecules. Springer, Ovarian Cancer, pp 495–511

Nuzhat Z, Kinhal V, Sharma S, Rice GE, Joshi V, Salomon C (2017) Tumour-derived exosomes as a signature of pancreatic cancer-liquid biopsies as indicators of tumour progression. Oncotarget 8(10):17279PubMed

Ogorevc E, Kralj-Iglic V, Veranic P (2013) The role of extracellular vesicles in phenotypic cancer transformation. Radiol Oncol 47(3):197–205PubMedPubMedCentral

Ohno S-I, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21(1):185–191PubMed

Ohno S-I, Drummen GP, Kuroda M (2016) Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems. Int J Mol Sci 17(2):172PubMedPubMedCentral

Oosthuyzen W, Sime NE, Ivy JR, Turtle EJ, Street JM, Pound J, Bath LE, Webb DJ, Gregory CD, Bailey MA (2013) Quantification of human urinary exosomes by nanoparticle tracking analysis. J Physiol 591(23):5833–5842PubMedPubMedCentral

Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM, Lunardi A, Webster K, Ng C, Newton RH (2014) Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157(3):595–610PubMedPubMedCentral

Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284(49):34211–34222PubMedPubMedCentral

Patil AA, Rhee WJ (2019) Exosomes: biogenesis, composition, functions, and their role in pre-metastatic niche formation. Biotechnol Bioprocess Eng 24(5):689–701

Phinney D, Pittenger M (2017) MSC-derived exosomes for cell-free therapy. Stem Cells 35:851–858PubMed

Pocsfalvi G, Stanly C, Vilasi A, Fiume I, Capasso G, Turiák L, Buzas EI, Vékey K (2016) Mass spectrometry of extracellular vesicles. Mass Spectrom Rev 35(1):3–21PubMed

Qindeel M, Sabir F, Sargazi S, Mohammadzadeh V, Mulla SI (2021) New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases. J Nanopart Res 23(11):1–27

Raimondo F, Morosi L, Chinello C, Magni F, Pitto M (2011) Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 11(4):709–720PubMed

Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383PubMedPubMedCentral

Record M, Carayon K, Poirot M, Silvente-Poirot S (2014) Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1841(1):108–120

Rojas C, Barnaeva E, Thomas AG, Hu X, Southall N, Marugan J, Chaudhuri AD, Yoo S-W, Hin N, Stepanek O (2018) DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation. Sci Rep 8(1):1–11

Roy B, Ghose S, Biswas S (2021) Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Semin Cell Dev Biol. https://doi.org/10.1016/j.semcdb.2021.04.006CrossRefPubMed

Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G, Altevogt P (2007) Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 107(3):563–571PubMed

Rupert DL, Lässer C, Eldh M, Block S, Zhdanov VP, Lotvall JO, Bally M, Höök F (2014) Determination of exosome concentration in solution using surface plasmon resonance spectroscopy. Anal Chem 86(12):5929–5936PubMed

Ryu KJ, Lee JY, Park C, Cho D, Kim SJ (2020) Isolation of small extracellular vesicles from human serum using a combination of ultracentrifugation with polymer-based precipitation. Ann Lab Med 40:253–258PubMed

Sandfeld-Paulsen B, Jakobsen KR, Bæk R, Folkersen BH, Rasmussen TR, Meldgaard P, Varming K, Jørgensen MM, Sorensen BS (2016) Exosomal proteins as diagnostic biomarkers in lung cancer. J Thorac Oncol 11(10):1701–1710PubMed

Sargazi S, Ahmadi Z, Barani M, Rahdar A, Amani S, Desimone MF, Pandey S, Kyzas GZ (2022a) Can nanomaterials support the diagnosis and treatment of human infertility? A preliminary review. Life Sci 5:120539

Sargazi S, Siddiqui B, Qindeel M, Rahdar A, Bilal M, Behzadmehr R, Mirinejad S, Pandey S (2022b) Chitosan nanocarriers for microRNA delivery and detection: a preliminary review with emphasis on cancer. Carbohydr Polym 290:119489PubMed

Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J, Calina D (2020) Potential therapeutic options for COVID-19: current status, challenges, and future perspectives. Front Pharmacol 11:572870PubMedPubMedCentral

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ (1994) Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer. J Clin Oncol 12(4):683–688PubMed

Shahraki K, Ahani A, Sharma P, Faranoush M, Bahoush G, Torktaz I, Gahl W, Naseripour M, Behnam B (2017) Genetic screening in Iranian patients with retinoblastoma. Eye 31(4):620–627PubMed

Shi Z-Y, Yang X-X, Malichewe C, Li Y-S, Guo X-L (2020) Exosomal microRNAs-mediated intercellular communication and exosome-based cancer treatment. Int J Biol Macromol 158:530–541PubMed

Skotland T, Sandvig K, Llorente A (2017) Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res 66:30–41PubMed

Sluijter JP, Verhage V, Deddens JC, van den Akker F, Doevendans PA (2014) Microvesicles and exosomes for intracardiac communication. Cardiovasc Res 102(2):302–311PubMed

Sohrabi B, Dayeri B, Zahedi E, Khoshbakht S, Nezamabadi Pour N, Ranjbar H, Davari Nejad A, Noureddini M, Alani B (2022) Mesenchymal stem cell (msc)-derived exosomes as novel vehicles for delivery of mirnas in cancer therapy. Cancer Gene Ther 29:1–12

Spugnini EP, Logozzi M, Di Raimo R, Mizzoni D, Fais S (2018) A role of tumor-released exosomes in paracrine dissemination and metastasis. Int J Mol Sci 19(12):3968PubMedPubMedCentral

Stalder L, Heusermann W, Sokol L, Trojer D, Wirz J, Hean J, Fritzsche A, Aeschimann F, Pfanzagl V, Basselet P (2013) The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. EMBO J 32(8):1115–1127PubMedPubMedCentral

Stolz A, Ernst A, Dikic I (2014) Cargo recognition and trafficking in selective autophagy. Nat Cell Biol 16(6):495–501PubMed

Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang H-G (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18(9):1606–1614PubMedPubMedCentral

Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H (2013) Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 119(6):1159–1167PubMed

Tatischeff I, Alfsen A (2011) A new biological strategy for drug delivery: eucaryotic cell-derived nanovesicles. J Biomater Nanobiotechnol 2(05):494

Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S (2015) Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updat 23:69–78PubMed

Tkach M, Théry C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164(6):1226–1232PubMed

Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, Tancini B, Emiliani C (2013) Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4(2):152–170PubMedPubMedCentral

Van den Boorn JG, Schlee M, Coch C, Hartmann G (2011) SiRNA delivery with exosome nanoparticles. Nat Biotechnol 29(4):325–326PubMed

Verderio C, Gabrielli M, Giussani P (2018) Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles. J Lipid Res 59(8):1325–1340PubMedPubMedCentral

Wahlgren J, Karlson TDL, Brisslert M, Vaziri Sani F, Telemo E, Sunnerhagen P, Valadi H (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40(17):e130–e130PubMedPubMedCentral

Wang H, Hou L, Li A, Duan Y, Gao H, Song X (2014) Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. BioMed Res Int 2014:1–5

Wang P, Wang H, Huang Q, Peng C, Yao L, Chen H, Qiu Z, Wu Y, Wang L, Chen W (2019a) Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics 9(6):1714PubMedPubMedCentral

Wang C, Chen L, Huang Y, Li K, Jinye A, Fan T, Zhao R, Xia X, Shen B, Du J (2019b) Exosome-delivered TRPP2 siRNA inhibits the epithelial-mesenchymal transition of FaDu cells. Oncol Lett 17(2):1953–1961PubMed

Wang H, He D, Wan K, Sheng X, Cheng H, Huang J, Zhou X, He X, Wang K (2020) In situ multiplex detection of serum exosomal microRNAs using an all-in-one biosensor for breast cancer diagnosis. Analyst 145(9):3289–3296PubMed

Whitford W, Guterstam P (2019) Exosome manufacturing status. Future Med Chem 11(10):1225–1236PubMed

Wilson K (2001) Preparation of genomic DNA from bacteria. Curr Protoc Mol Biol 56(1):2.4.1-2.4.5

Yan S, Han B, Gao S, Wang X, Wang Z, Wang F, Zhang J, Xu D, Sun B (2017) Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer. Oncotarget 8(36):60149PubMedPubMedCentral

Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S (2015) Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 32(6):2003–2014PubMedPubMedCentral

Yang Z, Xie J, Zhu J, Kang C, Chiang C, Wang X, Wang X, Kuang T, Chen F, Chen Z (2016) Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation. J Control Release 243:160–171PubMed

Yang T, Fogarty B, LaForge B, Aziz S, Pham T, Lai L, Bai S (2017) Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome nanovesicles for the treatment of brain cancer. AAPS J 19(2):475–486PubMed

Zaborowski MP, Balaj L, Breakefield XO, Lai CP (2015) Extracellular vesicles: composition, biological relevance, and methods of study. Bioscience 65(8):783–797PubMedPubMedCentral

Zakharova L, Svetlova M, Fomina AF (2007) T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 212(1):174–181PubMed

Zhang T, Li Y, Yu Y, Zou P, Jiang Y, Sun D (2009) Characterization of celastrol to inhibit hsp90 and cdc37 interaction. J Biol Chem 284(51):35381–35389PubMedPubMedCentral

Zhang X, Zhang Y, Li Y (2013) β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells. Oncol Rep 30(2):745–750PubMed

Zhang J, Yao Y-F, Zhong S-L, Zhao JH, Tang JH (2015) β-elemene reverses chemoresistance of breast cancer cells by reducing resistance transmission via exosomes. Cell Physiol Biochem 36(6):2274–2286PubMed

Zhang J, Yan S, Yuan D, Alici G, Nguyen N-T, Warkiani ME, Li W (2016) Fundamentals and applications of inertial microfluidics: a review. Lab Chip 16(1):10–34PubMed

Zhang X, Zheng H, Wang Y (2017) Protective effects of catalpol exosomes on damaged SH-SY5Y cells induced by low serum medium. Global Tradit Chin Med 10(2):155–158

Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9(1):1–18

Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P (2020a) Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed 15:6917

Zhang H, Lu J, Liu J, Zhang G, Lu A (2020b) Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem 35(1):1322–1330PubMedPubMedCentral

Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H (2020) Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. J Control Release 318:1–15PubMed

Zheng Z, Li Z, Xu C, Guo B, Guo P (2019) Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping. J Control Release 311:43–49PubMed

Zhu L, Wang K, Cui J, Liu H, Bu X, Ma H, Wang W, Gong H, Lausted C, Hood L (2014) Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging. Anal Chem 86(17):8857–8864PubMedPubMedCentral

Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Korvala J, Salo T, Sormunen R, Vered M (2015) Human saliva-derived exosomes: comparing methods of isolation. J Histochem Cytochem 63(3):181–189PubMedPubMedCentral

Title: An update in the applications of exosomes in cancer theranostics: from research to clinical trials
Authors: Kourosh Shahraki
Paria Ghasemi Boroumand
Hajie Lotfi
Fatemeh Radnia
Hossein Shahriari
Saman Sargazi
Sedigheh Sadat Mortazavi
Milad Shirvaliloo
Sakine Shirvalilou
Roghayeh Sheervalilou
Publication date: 03-04-2023
Publisher: Springer Berlin Heidelberg
Published in: Journal of Cancer Research and Clinical Oncology / Issue 10/2023
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-04701-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2023

Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers

Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors

Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis

Small molecule inhibitors for cancer metabolism: promising prospects to be explored

Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer

Day surgery unit robotics thoracic surgery: feasibility and management

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials